Literature DB >> 27683056

Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma.

Yadong Wang1, Shanfeng Zhang1, Yan Xu1, Yan Zhang2, Hongya Guan1, Xinjie Li1, Yuebai Li3, Yisheng Wang2.   

Abstract

MicroRNAs (miRNAs) can function as oncogenes or tumor suppressor genes and are involved in multiple processes in cancer development and progression. For example, miR-192 is dysregulated in multiple human cancers, including osteosarcoma (OS). However, the pathophysiological role of miR-192 and its relevance to OS cell growth and invasion has not yet been clarified. This study aimed to investigate the expression of miR-192 in OS and elucidate the molecular mechanisms by which miR-192 acts as a tumor suppressor in this disease. The qRT-PCR data identified significant down-regulation of miR-192 in 20 OS tissue samples and two OS cell lines when compared with adjacent normal tissues and a human osteoblast cell line, respectively. Furthermore, Western blot analysis revealed overexpression of T cell-specific transcription factor (TCF) 7 protein in tumor tissues compared with matched adjacent normal tissues. Further in vitro studies demonstrated that enforced expression of miR-192 inhibited U2OS and MG63 cell proliferation, invasion, and migration and induced apoptosis. Finally, Western blot and Luciferase assays identified TCF7 as a target of miR-192. Collectively, these findings suggest an important role for miR-192 in regulating the proliferation, migration, invasion, and apoptosis of OS cells through the regulation of TCF7.

Entities:  

Keywords:  Apoptosis; Invasion; Osteosarcoma; Proliferation; TCF7; miR-192

Mesh:

Substances:

Year:  2016        PMID: 27683056     DOI: 10.1007/s13277-016-5417-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  41 in total

1.  Regulation of growth of human bladder cancer by miR-192.

Authors:  Yongchao Jin; Jiasun Lu; Jiling Wen; Yinzhou Shen; Xiaofei Wen
Journal:  Tumour Biol       Date:  2015-01-09

2.  Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.

Authors:  Yuan Wang; Lian-Shun Jia; Wen Yuan; Zhao Wu; Hai-Bo Wang; Tao Xu; Jing-Chuan Sun; Ke-Fu Cheng; Jian-Gang Shi
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

3.  Survivin over-expression is correlated with a poor prognosis in esophageal cancer patients.

Authors:  Haifeng Xia; Shaomu Chen; Haitao Huang; Haitao Ma
Journal:  Clin Chim Acta       Date:  2015-04-17       Impact factor: 3.786

4.  Effect of survivin on tumor growth of colorectal cancer in vivo.

Authors:  Yongping Cai; Wei Ma; Xiaojuan Huang; Liyu Cao; Hao Li; Yan Jiang; Nana Lu; Yu Yin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 5.  Survivin in survival of hepatocellular carcinoma.

Authors:  Changqing Su
Journal:  Cancer Lett       Date:  2015-06-25       Impact factor: 8.679

6.  Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.

Authors:  François-Xavier Dieudonné; Allison Marion; Pierre J Marie; Dominique Modrowski
Journal:  J Bone Miner Res       Date:  2012-10       Impact factor: 6.741

7.  Tcf/Lef transcription factors during T-cell development: unique and overlapping functions.

Authors:  F J Staal; H Clevers
Journal:  Hematol J       Date:  2000

8.  MicroRNA-144 acts as a tumor suppressor by targeting Rho-associated coiled-coil containing protein kinase 1 in osteosarcoma cells.

Authors:  Jianjun Huang; Ying Shi; Hui Li; Meisongzhu Yang; Guohong Liu
Journal:  Mol Med Rep       Date:  2015-06-16       Impact factor: 2.952

9.  MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer.

Authors:  Wei-Yu Chen; Shih-Yang Liu; Yung-Sheng Chang; Juan Juan Yin; Hsiu-Lien Yeh; Tarek H Mouhieddine; Ola Hadadeh; Wassim Abou-Kheir; Yen-Nien Liu
Journal:  Oncotarget       Date:  2015-01-01

Review 10.  Zinc and cancer: implications for LIV-1 in breast cancer.

Authors:  Bruce J Grattan; Hedley C Freake
Journal:  Nutrients       Date:  2012-07-04       Impact factor: 5.717

View more
  13 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  MicroRNA-192-5p suppresses the initiation and progression of osteosarcoma by targeting USP1.

Authors:  Sheng Zhou; Min Xiong; Guo Dai; Ling Yu; Zhengpei Zhang; Jie Chen; Weichun Guo
Journal:  Oncol Lett       Date:  2018-03-06       Impact factor: 2.967

3.  miR-6852 serves as a prognostic biomarker in colorectal cancer and inhibits tumor growth and metastasis by targeting TCF7.

Authors:  Bao-Hong Cui; Xuan Hong
Journal:  Exp Ther Med       Date:  2018-06-07       Impact factor: 2.447

Review 4.  What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?

Authors:  Gaia Palmini; Francesca Marini; Maria Luisa Brandi
Journal:  Molecules       Date:  2017-03-07       Impact factor: 4.411

5.  MicroRNA‑590 inhibits migration, invasion and epithelial‑to‑mesenchymal transition of esophageal squamous cell carcinoma by targeting low‑density lipoprotein receptor‑related protein 6.

Authors:  Hongya Guan; Jia Liu; Pengju Lv; Lijuan Zhou; Jianying Zhang; Wei Cao
Journal:  Oncol Rep       Date:  2020-07-15       Impact factor: 3.906

6.  Inhibition of miR‑194 suppresses the Wnt/β‑catenin signalling pathway in gastric cancer.

Authors:  Yin Peng; Xiaojing Zhang; Huijuan Lin; Shiqi Deng; Yong Huang; Ying Qin; Xianling Feng; Ruibin Yan; Yanqiu Zhao; Yulan Cheng; Yanjie Wei; Jian Wang; Wangchun Chen; Xinmin Fan; Hassan Ashktorab; Duane Smoot; Stephen J Meltzer; Song Li; Zhong Zhang; Zhe Jin
Journal:  Oncol Rep       Date:  2018-10-08       Impact factor: 3.906

7.  NAIF1 suppresses osteosarcoma progression and is regulated by miR-128.

Authors:  Daliang Kong; Zhe Zhang
Journal:  Cell Biochem Funct       Date:  2018-11-08       Impact factor: 3.685

8.  New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144.

Authors:  Francisco Hernández-Walias; María J Ruiz-de-León; Isaac Rosado-Sánchez; Esther Vázquez; Manuel Leal; Santiago Moreno; Francesc Vidal; Julià Blanco; Yolanda M Pacheco; Alejandro Vallejo
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

9.  MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.

Authors:  Qingli Huang; Sen Hou; Xiuqing Zhu; Shouzhou Liu
Journal:  World J Surg Oncol       Date:  2020-02-03       Impact factor: 2.754

10.  Circular RNA hsa_circ_0000282 contributes to osteosarcoma cell proliferation by regulating miR-192/XIAP axis.

Authors:  Houkun Li; Limin He; Yuan Tuo; Yansheng Huang; Bing Qian
Journal:  BMC Cancer       Date:  2020-10-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.